SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-18-009700
Filing Date
2018-02-20
Accepted
2018-02-20 09:44:33
Documents
4
Group Members
CURT LABELLEPRIVATE MEDICAL EQUITY, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13D tv486224_sc13d.htm SC 13D 94893
2 EXHIBIT 10.1 tv486224_ex10-1.htm EX-10.1 18868
3 EXHIBIT 10.2 tv486224_ex10-2.htm EX-10.2 18778
4 EXHIBIT 99.1 tv486224_ex99-1.htm EX-99.1 6567
  Complete submission text file 0001144204-18-009700.txt   140381
Mailing Address 8748 TECHNOLOGY WAY RENO NV 89521
Business Address 8748 TECHNOLOGY WAY RENO NV 89521 813-766-9539
EYENOVIA, INC. (Subject) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90395 | Film No.: 18623367
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 501 FIFTH AVENUE SUITE 1404 NEW YORK NY 10017
Business Address
Ianchulev Tsontcho (Filed by) CIK: 0001728916 (see all company filings)

Type: SC 13D